Oracle Pharma is a rapidly expanding international pharmaceutical firm that creates, produces, and distributes generic, biosimilar, and added-value medications. By doing so, it helps patients have better access to critical pharmaceutical treatment when they need it.

By challenging the status quo and directly addressing unmet clinical and societal needs, Accord works tirelessly to improve things by providing patients with high-quality medicines in a timely, cost-effective, reliable, and innovative manner.

The therapeutic areas included in Oracle Pharma’s portfolio include oncology, cardiology, neurology, psychiatry, diabetes, pain management, and gastrointestinal.